Skip Navigation

Blood Disorders and Blood SafetyNew

Hemoglobinopathies

Bleeding and Clotting

Baseline: 54.3 persons per 10,000 population aged 18 years and older developed venous thromboembolism (VTE) in 2007 (age adjusted to the year 2000 standard population)
Target: 48.9 per 10,000 population
Target-Setting Method: 10 percent improvement
Data Sources: National Ambulatory Medical Care Survey (NAMCS), CDC/NCHS; National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC/NCHS
Data:
Data for this objective HP2020 data for this objective
Data Details Details about the methodology and measurement of this HP2020 objective
Close Details
BDBS-13     (Developmental) Reduce the number of adults who develop venous thromboembolism (VTE) during hospitalization
Baseline: 28.4 percent of females with von Willebrand disease (vWD) were timely and accurately diagnosed in 2008
Target: 31.2 percent
Target-Setting Method: 10 percent improvement
Data Source: Universal Data Collection System (UDC), CDC/NCBDDD
Data:
Data for this objective HP2020 data for this objective
Data Details Details about the methodology and measurement of this HP2020 objective
Close Details
Baseline: 82.9 percent of persons with hemophilia developed reduced joint mobility due to bleeding into joints in 2008
Target: 74.6 percent
Target-Setting Method: 10 percent improvement
Data Source: Universal Data Collection System (UDC), CDC/NCBDDD
Data:
Data for this objective HP2020 data for this objective
Data Details Details about the methodology and measurement of this HP2020 objective
Close Details

Blood Safety

Baseline: 6.1 percent of the population aged 18 years and older reported donating blood within the past year in 2008 (age adjusted to the year 2000 standard population)
Target: 6.7 percent
Target-Setting Method: 10 percent improvement
Data Source: National Health Interview Survey (NHIS), CDC/NCHS
Data:
Data for this objective HP2020 data for this objective
Data Details Details about the methodology and measurement of this HP2020 objective
Healthy People 2010 HP2010 data for this objective
Close Details
BDBS-18     (Developmental) Reduce the proportion of persons who develop adverse events resulting from the use of blood and blood products.
BDBS-19     (Developmental) Reduce the proportion of persons who did not receive a transfusion due to a blood product shortage.

Back to Top